How I reduce and treat posttransplant relapse of MDS
A Mina, PL Greenberg, HJ Deeg - Blood, 2024 - ashpublications.org
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only potentially curative
option for patients with high-risk myelodysplastic syndromes (MDS). Advances in …
option for patients with high-risk myelodysplastic syndromes (MDS). Advances in …